Technology

We are looking for a VP Marketing with a proven track record of driving growth

Find your next must-read industry newsletter Where do you go when you’re hungry for curated

An at-a-glance overview of the evolving cybersecurity threat landscape Keeping up with the most critical

New Feature Declutter your inbox and read without distractions Newsletters are quickly becoming the best

Leo We’re designing systems to protect against machine learning bias In the wake of recent

New Feature Pull content from Twitter accounts, hashtags, Lists, and searches directly into your Feedly

Save time and find the biopharma content you need The amount of information published every

Streamline your biopharma intelligence Today, we’re excited to launch Feedly for Biopharma to help biopharma

New Feature Track your competitors efficiently The biopharma space has become more and more competitive.

Research genes and learn more about the latest breakthroughs more efficiently Drug development is a

Streamline your biopharma intelligence by adding custom ClinicalTrials.gov feeds to your Feedly. Clinical trial updates

Research biomedical literature by following custom PubMed feeds on Feedly. Scientific journals produce overwhelming amounts

We heard from lots of biopharma users that the Drugs topic could be improved and

Streamline your open-source intelligence 150,000 cybersecurity professionals use Feedly to keep up with the latest

Research and prepare for the latest malware threats without the information overload Cybersecurity is a

Research threat actor groups and learn more about their tactics, techniques, and procedures without the

Feedly for Cybersecurity includes an API that allows cybersecurity teams to share the threat intelligence

Train Leo to prioritize the most critical vulnerabilities in your cybersecurity feeds Do you need

Look beyond the big headlines. Leo can show you exactly what’s happening to your industry

The internet is a cavernous place. Opinion and insight can emerge from anywhere. Whether you’re